BAFF and BAFF-R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura

被引:55
作者
Zhou, Zeping
Chen, Zhenping
Li, Hongqiang
Chen, Xiaoli
Xu, Jianhui
Gu, Dongsheng
Du, Weiting
Zheng, Cuiling
Zhang, Lei
Huang, Ying
Ren, Qian
Yang, Renchi [1 ]
机构
[1] Chinese Acad Med Sci, Inst Hematol & Blood Dis Hosp, State Key Lab Expt Hematol, Tianjin 300020, Peoples R China
基金
中国国家自然科学基金;
关键词
Idiopathic thrombocytopenic purpura; BAFF; BAFF-R; spleen; peripheral blood; SYSTEMIC-LUPUS-ERYTHEMATOSUS; LYMPHOCYTE ACTIVATING FACTOR; NECROSIS-FACTOR FAMILY; B-CELLS; FACTOR-RECEPTOR; T-CELLS; SERUM; EXPRESSION; OVEREXPRESSION; SPLENECTOMY;
D O I
10.1080/08916930802397848
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
BAFF (B-cell activating factor belonging to the TNF family) is an essential component of B-cell homeostasis, and is required for the normal survival and development of B cells. To further explore the role of this cytokine in the pathogenesis of idiopathic thrombocytopenic purpura (ITP), BAFF/BAFF-R (one of receptors of BAFF) expression levels were determined and the correlation between the clinical parameters and the BAFF expression levels was analyzed. A total of 57 patients with ITP were enrolled and 25 age and sex-matched healthy volunteers served as controls. Serum was obtained from 41 patients with ITP and 22 healthy volunteers and was analyzed with a commercial human soluble BAFF (sBAFF) ELISA kit. BAFF and BAFF-R mRNA expression of peripheral blood (PB) (n=42) and splenocytes (SP) (n=8) mononuclear cells (MNC) were determined by real-time quantitative PCR. The SPMNC of normal controls came from three hereditary spherocytosis patients who underwent splenectomy. The untreated patients with ITP had higher serum BAFF levels (Median 1430pg/ml, Range: 534-5787pg/ml) than those of normal controls (Median 1120pg/ml, Range: 640-2376pg/ml, p=0.006) and treated ITP group (Median 662pg/ml, Range 267-1265pg/ml, p=0.000). On the other hand, serum BAFF levels of treated patients with ITP were lower than those of normal controls (p=0.001). There was a weak correlation (the Pearson correlation coefficient is -0.242) between platelet count and BAFF (p=0.064). However, BAFF levels did not correlate with platelet associated immunoglobulin or immunoglobulin levels. Moreover, the serum BAFF levels were not statistically different between acute and chronic ITP (p=0.841). PBMNC of ITP had higher BAFF but not BAFF-R mRNA expression than that of normal controls. BAFF mRNA expression of SPMNC had a positive correlation with BAFF-R in ITP patients but not in PBMNC of normal controls and untreated ITP patients. The BAFF-R mRNA expression of SPMNC was shown to be 15.29 times higher than that of PBMNC in ITP. BAFF might contribute to autoimmunity and disease development in ITP. However, BAFF serum level must be carefully considered as a surrogate marker of disease activity in ITP.
引用
收藏
页码:112 / 119
页数:8
相关论文
共 43 条
[1]   B-lymphocyte activating factor in systemic lupus erythematosus and rheumatoid arthritis in relation to autoantibody levels, disease measures and time [J].
Becker-Merok, A. ;
Nikolaisen, C. ;
Nossent, H. C. .
LUPUS, 2006, 15 (09) :570-576
[2]   Expression and occupancy systemic lupus of BAFF-R on B cells in erythematosus [J].
Carter, RH ;
Zhao, H ;
Liu, XM ;
Pelletier, M ;
Chatham, W ;
Kimberly, R ;
Zhou, T .
ARTHRITIS AND RHEUMATISM, 2005, 52 (12) :3943-3954
[3]  
Cheema GS, 2001, ARTHRITIS RHEUM-US, V44, P1313, DOI 10.1002/1529-0131(200106)44:6<1313::AID-ART223>3.0.CO
[4]  
2-S
[5]   Medical progress: Immune thrombocytopenic purpura. [J].
Cines, DB ;
Blanchette, VS .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (13) :995-1008
[6]   High-level serum B-cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura [J].
Emmerich, Florian ;
Bal, Guerkan ;
Barakat, Alaa ;
Milz, Julian ;
Muehle, Caroline ;
Martinez-Gamboa, Lorena ;
Doerner, Thomas ;
Salama, Abdulgabar .
BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (02) :309-314
[7]   Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren's syndrome [J].
Groom, J ;
Kalled, SL ;
Cutler, AH ;
Olson, C ;
Woodcock, SA ;
Schneider, P ;
Tschopp, J ;
Cachero, TG ;
Batten, M ;
Wheway, J ;
Mauri, D ;
Cavill, D ;
Gordon, TP ;
Mackay, CR ;
Mackay, F .
JOURNAL OF CLINICAL INVESTIGATION, 2002, 109 (01) :59-68
[8]   BAFF production by antigen-presenting cells provides T cell co-stimulation [J].
Huard, B ;
Arlettaz, L ;
Ambrose, C ;
Kindler, V ;
Mauri, D ;
Roosnek, E ;
Tschopp, J ;
Schneider, P ;
French, LE .
INTERNATIONAL IMMUNOLOGY, 2004, 16 (03) :467-475
[9]   A BAFF antagonist suppresses experimental autoimmune encephalomyelitis by targeting cell-mediated and humoral immune responses [J].
Huntington, Nicholas D. ;
Tomioka, Ryo ;
Clavarino, Chelsea ;
Chow, Anne M. ;
Linares, David ;
Mana, Paula ;
Rossjohn, Jamie ;
Cachero, Teresa G. ;
Qian, Fang ;
Kalled, Susan L. ;
Bernard, Claude C. A. ;
Reid, Hugh H. .
INTERNATIONAL IMMUNOLOGY, 2006, 18 (10) :1473-1485
[10]   Association between circulating levels of the novel TNF family members APRIL and BAFF and lymphoid organization in primary Sjogren's syndrome [J].
Jonsson, MV ;
Szodoray, P ;
Jellestad, S ;
Jonsson, R ;
Skarstein, K .
JOURNAL OF CLINICAL IMMUNOLOGY, 2005, 25 (03) :189-201